Add Yahoo as a preferred source to see more of our stories on Google. Considering treatment options can feel like an overwhelming process for many people newly diagnosed with HIV. That being said, as ...
A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...
A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
ART scale-up to ~80% coverage by 2024 reduced AIDS deaths from ~2 million (2004) to just over 500,000 annually, alongside a 40% decline in incident infections since 2010. Regional divergence is ...
Three individuals have been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for their work on the drug American Association for the Advancement of Science (AAAS) In the hunt for a ...
Researchers conducted a randomized trial in seven European countries to compare the efficacy and safety of an integrase inhibitor-containing antiretroviral regimen vs a boosted protease ...
Researchers conducted a retrospective, multinational study across 15 European treatment centers to assess the efficacy and tolerability of DTG/3TC vs BIC/TAF/FTC as first‑line therapy in ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Example antibody-drug conjugate A recent experimental treatment may offer a new method to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results